Investing Profile

Poul Sørensen

InvestorVC
Partner at Ventac Partners
ventac-partners.com/about-us/...Paris, France
Photo of Poul Sørensen, Partner at Ventac Partners
Your Intro Paths to Poul Sørensen

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Poul Sørensen on

cb
Current Investing Position
Ventac Partners Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M

Poul Sørensen is on these Sector & Stage Rankings

Poul Sørensen's Experience

Partner and Entrepreneur-in-Residence ARGOBIO2022 - Present
Co-founder & Chief Scientific Officer Allero Therapeutics2016 - Present
Honorary Professor of Biomedicine Aarhus University2015 - Present
Partner Ventac Partners2018 - 2022
Global Head of Corporate Strategy & Business Development Medday Pharmaceuticals2019 - 2020
Senior Vice President, Global Head of Strategic Development Stallergenes Greer2012 - 2017
Vice President, Global Research ALK Abelló2008 - 2012
Member Board Of Directors Biotech Research & Innovation Centre (BRIC), University of Copenhagen2005 - 2011
Research Director LEO Pharma2005 - 2008
Vice President, Head of Antibody Therapeutics Business Unit Micromet AG2003 - 2004
Director, Biopharmaceutical Project Portfolio Maxygen, Inc2001 - 2003
Head of Biology Active Biotech Research AB1998 - 2001
Scientific Project Leader Pharmacia & Upjohn1994 - 1998
Research associate/PhD student Carlsberg Laboratory1989 - 1994

Poul Sørensen's Education

University of Copenhagen Ph.D Biochemistry
University of Aarhus M.Sc Molecular Genetics
Aarhus Statsgymnasium High School